PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
37.14%
Positive revenue growth while 1097.HK is negative. John Neff might see a notable competitive edge here.
34.50%
Positive gross profit growth while 1097.HK is negative. John Neff would see a clear operational edge over the competitor.
-29.21%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
8.25%
Positive operating income growth while 1097.HK is negative. John Neff might view this as a competitive edge in operations.
-28.65%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-30.77%
Negative EPS growth while 1097.HK is at 13.56%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-30.77%
Negative diluted EPS growth while 1097.HK is at 13.56%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.24%
Share reduction more than 1.5x 1097.HK's 32.14%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.24%
Diluted share reduction more than 1.5x 1097.HK's 32.14%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-2.56%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1.94%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-3.78%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
11301.73%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
543.21%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-154.74%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
29.96%
Positive OCF/share growth while 1097.HK is negative. John Neff might see a comparative advantage in operational cash viability.
-90.57%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-552.26%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-1545.34%
Negative 5Y net income/share CAGR while 1097.HK is 27.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
40.64%
3Y net income/share CAGR 1.25-1.5x 1097.HK's 32.34%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
-13.62%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-40.12%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Negative 5Y dividend/share CAGR while 1097.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 1097.HK shows 1.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
20.44%
Inventory growth well above 1097.HK's 1.09%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.34%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-8.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
24.79%
Debt growth of 24.79% while 1097.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-57.76%
We cut SG&A while 1097.HK invests at 16.15%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.